Edwards sues Medtronic on annuloplasty rings:
This article was originally published in Clinica
The US heart valve supplier Edwards Lifesciences has launched another lawsuit against Medtronic, accusing it of infringing patents related to heart valve repair. The new suit, filed in the US district court in Delaware, alleges that Medtronic's Duran range infringes Edwards' patent on annuloplasty ring delivery systems used in surgical suturing. Last year Edwards sued Medtronic claiming that various products, including Duran and the Hancock II and Mosaic aortic heart valves, infringed three other Edwards patents. Medtronic is contesting the suits. It claims that it is not infringing the Edwards patents and that they are invalid anyway.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.